New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
News|Slideshows|May 1, 2024
The 10 States with the Largest ↑ Increase in Diabetes Dx & 5 States with the Largest ↓ Decrease
Author(s)Grace Halsey
Diagnoses of diabetes increased the most in South Dakota between 2018 and 2021 at 18.45%; diagnoses decreased the most in Hawaii at 15.61%. More, here.
Advertisement
Diabetes awareness website Diabetes Strong analyzed data from the US Centers for Disease Control and Prevention, comparing the number of adults diagnosed with diabetes in each state in 2018 and in 2021 (the latter is the most recent data set). The comparisons create a topline look at the current prevalence of diabetes in the US.
Spoiler: South Dakota tops the list of states with a double-digit increase over the 3 years (18.45%) and Hawaii saw the greatest decreases in diabetes diagnoses over the same period (15.61%), according to the results.
Liitations to the data: No differentiation is made between types of diabetes so there is no way to know which type/s are increasing/decreasing most; also, only adults aged 18 years and older were included so type 1 diabetes diagnoses are likely underrepresented, the majority of those being made before age 18.
Source: Oerum C. Diabetes rates rise in most (but not all) US states. Diabetes Strong. Updated April 30, 2024. Accessed April 30, 2024. https://diabetesstrong.com/diabetes-rates-by-us-state/
Advertisement
Related to this article
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.
Insulin icodec is now available in the US after FDA approval, offering adults with type 2 diabetes a once-weekly basal insulin option.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Advertisement
Advertisement
Trending on Patient Care Online
1
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
2
Type 2 Diabetes, Genetic Risk Linked to MASLD Cirrhosis Before Age 50
3
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
4
Lyme Seropositivity Linked to Tick-Borne Co-Exposure in US Laboratory Study
5